Brian Webster
Brian Webster is Chief Executive Officer at Kestra Medical Technologies and President & CEO at Physio-Control, now part of Stryker.
Kestra Medical Technologies Secures Up to $200M Five-Year Non-Dilutive Term Loan from Pharmakon Advisors
Kestra Medical Technologies secured a five-year, non-dilutive term loan facility with Pharmakon Advisors totaling up to $200 million in tranches — $75 million funded at closing — to refinance existing debt, support growth and provide liquidity. The deal features 48 months of interest-only payments, SOFR+5.5% interest (3.25% SOFR floor), contingent tranches tied to timing and a $150 million revenue milestone, leaving Kestra with about $357 million total liquidity.
Kestra Medical Technologies Raises $196M to Expand Commercialization of FDA-Approved Wearable Defibrillator
Kestra Medical Technologies raised $196 million to accelerate commercialization of its FDA-approved Wearable Cardioverter Defibrillator, designed to meet female cardiac patients' needs. The funding round was co-led by Andera Partners, Ally Bridge Group, Longitude Capital, and Omega Funds, increasing total funding to $496 million.
Organizations
-
Kestra Medical Technologies Chief Executive Officer 2016–present · current
-
Physio-Control, now part of Stryker President & CEO 2006–2016 · current
Education
-
Seattle University Master of Business Administration (MBA), Business Administration and Management, General · 1990–1992
-
University of Puget Sound BA, Business · 1982–1986